Hemostemix Inc's stock has taken a significant hit, dropping over 9% in the last trading session.
In the latest trading session, Hemostemix Inc (HEM.V) experienced a sharp decline, closing down 9.09% at CA$0.05. This drop raises concerns among investors about the company's current standing and future prospects.
Advertisement
Get up to $2,000 cash back
Open and fund a new Qtrade account with promo code SPRING26. Offer ends July 31, 2026.
Hemostemix Inc
HEM.V
HEM.V
Hemostemix Inc
WealthAwesomeMarket cap
$11.27M
52W high
$0.15
52W low
$0.04
1W change
+0.00%
Beta
0.62
Analyst Price Targets
Based on analyst covering HEM
Wall Street analysts forecast HEM stock price to rise 1645.5% over the next 12 months.
Consensus
No RatingAvg. Target
C$0.96
+1645.5% Upside
Current Price
C$0.06
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on HEM's historical volatility
30-Day Vol
105.0%
Annualized
90-Day Vol
96.7%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.05 | C$0.04 โ C$0.07 |
| 60 trading days | C$0.05 | C$0.03 โ C$0.08 |
| 90 trading days | C$0.05 | C$0.02 โ C$0.09 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should closely monitor Hemostemix's financial health and market developments, as the recent price drop may indicate underlying issues that could impact future performance.
HEM.V down 9.09% in one day
The market cap has fallen to CA$10.25 million, reflecting investor concerns about Hemostemix's financial viability.
Bull case
If Hemostemix can effectively use its recent private placements to fund key initiatives, it might regain investor confidence and stabilize its stock price.
Bear case
On the other hand, continued losses and a lack of positive news could lead to further declines, putting investor capital and the company's market position at risk.
Recent Performance Overview
Hemostemix Inc's stock fell sharply by 9.09%, closing at CA$0.05. This decline is notable given the company's recent attempts to raise capital through private placements, which may not have instilled the confidence investors were hoping for.
Market Reactions and Future Outlook
The market's reaction to Hemostemix's performance shows a cautious sentiment among investors. With a market cap now at CA$10.25 million, stakeholders will be watching closely for any developments that could either stabilize or further destabilize the stock.
What Investors Should Watch For
Investors should keep an eye on Hemostemix's upcoming announcements and financial reports. The company's ability to effectively utilize funds from recent private placements could be crucial in shaping its recovery trajectory.
Advertisement
